This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huff, T. A. Articles by Davis, L. Search for Related Content PubMed PubMed Citation Articles by Huff, T. A. Articles by Davis, L.

(Stroke. 1972;3:543.)
© 1972 American Heart Association, Inc.

---

Serial Changes in Glucose Utilization and Insulin and Growth Hormone Secretion in Acute Cerebrovascular Disease

T. A. Huff M.D.¹; H. E. Lebovitz M.D.²; A. HEYMAN M.D.²; L. Davis B.A.²

¹ Medical College of Georgia, Department of Medicine, Division of Endocrinology, Augusta, Georgia
² Divisions of Endocrinology and Neurology, Department of Medicine, Duke University Medical Center Durham, North Carolina

Serial studies were made of glucose utilization and insulin and growth hormone secretion following intravenous glucose tolerance tests given to 16 patients during recovery from acute cerebrovascular disease. Three groups of patients were identified based on the pattern of change of glucose utilization during the first month of convalescence. A small group showed a persistent defective insulin response to glucose and appeared to have had pre-existing unrecognized adult-onset diabetes mellitus. The two other groups showed either an immediate suppression of glucose utilization or delayed development of glucose intolerance associated with an increase in total insulin secretion. Both of these responses returned to normal by the end of the fourth week. Growth hormone secretion correlated with the severity of the stroke. Alterations in glucose metabolism and insulin secretion seem to occur in most patients following recovery from stroke and undoubtedly reflect transient hormonal or metabolic changes related to either acute stress or tissue injury, depending on the interval after the onset of the vascular episode.

Key Words: diabetes mellitus • cerebral infarction • hyperglycemia • intracranial hemorrhage

This article has been cited by other articles:

				W. N. Kernan, S. E. Inzucchi, C. M. Viscoli, L. M. Brass, D. M. Bravata, G. I. Shulman, J. C. McVeety, and R. I. Horwitz Pioglitazone Improves Insulin Sensitivity Among Nondiabetic Patients With a Recent Transient Ischemic Attack or Ischemic Stroke Stroke, June 1, 2003; 34(6): 1431 - 1436. [Abstract] [Full Text] [PDF]

				W. N. Kernan, S. E. Inzucchi, C. M. Viscoli, L. M. Brass, D. M. Bravata, G. I. Shulman, J. C. McVeety, and R. I. Horwitz Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke Neurology, May 13, 2003; 60(9): 1447 - 1451. [Abstract] [Full Text] [PDF]

				D. B. Matchar, G. W. Divine, A. Heyman, and J. R. Feussner The Influence of Hyperglycemia on Outcome of Cerebral Infarction Ann Intern Med, September 15, 1992; 117(6): 449 - 456. [Abstract] [PDF]